These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6144546)

  • 1. The multiple modes of action of propafenone.
    Dukes ID; Vaughan Williams EM
    Eur Heart J; 1984 Feb; 5(2):115-25. PubMed ID: 6144546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations.
    Ledda F; Mantelli L; Manzini S; Amerini S; Mugelli A
    J Cardiovasc Pharmacol; 1981; 3(6):1162-73. PubMed ID: 6173515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of propafenone on isolated guinea-pig ventricular muscle and sheep Purkinje fibres.
    Tamargo J; Delgado C
    Eur J Pharmacol; 1985 Dec; 118(3):331-40. PubMed ID: 4085559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic effects of propafenone on canine ischemic cardiac cells.
    Zeiler RH; Gough WB; El-Sherif N
    Am J Cardiol; 1984 Aug; 54(3):424-9. PubMed ID: 6465028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of propafenone on the membrane currents of rabbit sino-atrial node cells.
    Satoh H; Hashimoto K
    Eur J Pharmacol; 1984 Mar; 99(2-3):185-91. PubMed ID: 6734728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.
    von Philipsborn G; Gries J; Hofmann HP; Kreiskott H; Kretzschmar R; Müller CD; Raschack M; Teschendorf HJ
    Arzneimittelforschung; 1984; 34(11):1489-97. PubMed ID: 6543124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differentiation of propafenone from other class Ic agents, focusing on the effect on ventricular response rate attributable to its beta-blocking action.
    Faber TS; Camm AJ
    Eur J Clin Pharmacol; 1996; 51(3-4):199-208. PubMed ID: 9010685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenergic stimulation modulates the sodium current block by propafenone in rat ventricular myocardium.
    Maier SK; Kirstein M
    J Electrocardiol; 2002 Oct; 35(4):343-9. PubMed ID: 12395362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres.
    Delgado C; Tamargo J; Tejerina T
    Br J Pharmacol; 1985 Dec; 86(4):765-75. PubMed ID: 4075015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
    Schmitz W
    Klin Wochenschr; 1980 Sep; 58(18):907-18. PubMed ID: 6110804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of Org 7797, a new steroidal antiarrhythmic agent: comparison with class 1a, 1b, and 1c drugs.
    Winslow E; Martorana M; Bell P
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):205-12. PubMed ID: 2476592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of propafenone on slow response action potential and the slow inward current of the myocardium].
    Xu YQ; Liu YM; Gao RB; Mei YA; Xu JM
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):138-40. PubMed ID: 2946151
    [No Abstract]   [Full Text] [Related]  

  • 13. Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.
    McLeod AA; Stiles GL; Shand DG
    J Pharmacol Exp Ther; 1984 Feb; 228(2):461-6. PubMed ID: 6141285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophysiologic and anti-arrhythmia properties of propafenone deducible from experimental studies in vitro].
    Ledda F; Mantelli L
    G Ital Cardiol; 1984 Apr; 14(4):279-84. PubMed ID: 6329868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential effects of a new anti-arrhythmia agent (propafenon) on the Purkinje and myocardial activity filaments].
    Bolte HD; Bergmann M; Tebbe U
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1239-42. PubMed ID: 1029968
    [No Abstract]   [Full Text] [Related]  

  • 17. [New antiarrhythmia agents: propafenone and flecainide].
    Leclercq JF
    Presse Med; 1985 Mar; 14(12):685-9. PubMed ID: 3157964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of propafenon in myocardial refractoriness].
    Mill JG
    Arq Bras Cardiol; 1981 Jan; 36(1):35-9. PubMed ID: 7271516
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
    Groschner K; Lindner W; Schnedl H; Kukovetz WR
    Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
    Zaza A; Malfatto G; Schwartz PJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):336-43. PubMed ID: 8169840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.